In the ever-evolving field of diabetes management, GLP-1 receptor agonists have emerged as a transformative therapeutic class. Among these, retaglutide, retatrutide, and trizepatide represent promising additions to the https://brontegamc721912.is-blog.com/45948431/novel-glp-1-receptor-agonists-retaglutide-retatrutide-and-trizepatide